From ASCEND-5 to ALUR to ALTA-3, an Anti-Climactic End to the Era of Randomized Phase 3 Trials of Next-Generation ALK TKIs in the Crizotinib-Refractory Setting
-
Published:2023-06
Issue:
Volume:Volume 14
Page:57-62
-
ISSN:1179-2728
-
Container-title:Lung Cancer: Targets and Therapy
-
language:en
-
Short-container-title:LCTT
Author:
Lee Alexandria TMORCID,
Ou Saihong IgnatiusORCID
Publisher
Informa UK Limited